Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rumor
Pharma
What really happened with Pascal Soriot and Teva?
The truth behind the AstraZeneca CEO's rumored move to Teva could be complicated—or not.
Tracy Staton
Jul 17, 2017 11:27am
FiercePharmaAsia—Celgene’s $1.4B Beigene deal, Neopharma expands
Jul 7, 2017 8:31am
Fosun stumbles over rumors of chairman disappearance—again
Jul 7, 2017 8:06am
Deal talk matches BMS with Pfizer, Roche or Novartis. Really?
Feb 15, 2017 10:53am
